We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Delivering Portable Chest Radiography Through Glass (TG-CXR) Reduces COVID-19 Infection Risk in Hospitals

By HospiMedica International staff writers
Posted on 20 Apr 2021
Illustration
Illustration
A study to understand the cost and benefit of adopting portable chest radiography through glass (TG-CXR) at a tertiary care centre during the COVID-19 pandemic has found the novel technique to be particularly beneficial.

A team of two technologists at the Department of Radiology, St. Michael's Hospital, University of Toronto (Toronto, ON, Canada) were trained on the TG-CXR method which has the benefit of allowing one technologist to stay outside of the patient room while operating the portable radiography machine, thus reducing PPE use, decreasing the frequency of radiography machine sanitization and reducing their exposure to potentially infectious patients.

The cost of implementing the technique during the current COVID-19 pandemic was obtained from the department's operational database. The direct cost of routinely used PPE and sanitization materials and the cost of the time taken by the technologists to clean the machine was used to form a quantitative picture of the benefit associated with TG-CXR technique.

The technologists were trained on the TG-CXR method during a 15 minute shift change briefing. This translated to a one-time cost of USD 424.88. There was an average reduction of portable radiography machine downtime of four minutes and 48 seconds per study. The benefit of adopting the TG-CXR technique was USD 9.87 per patient imaged, resulting in a projected net cost savings of USD 51,451.84 per annum. Thus, the study concluded that adoption of the TG-CXR technique during the COVID-19 pandemic involves a minimal one-time cost, but can result in a significant benefit over the year.

"We hope that our findings would encourage policy-makers to implement TG-CXR technique at their institutions when and where possible," the study concluded.

Related Links:
University of Toronto

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Surgical Dressing
ALLEVYN Ag+ SURGICAL

Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more